Mounjaro®
Starting from £179.99/mo
Start journey Learn moreHeart palpitations on Wegovy do occur, and the most common cause is not the medicine acting on your heart directly — it's the body's response to rapid fluid shifts and reduced calorie intake in the early weeks of treatment. Semaglutide itself is not a cardiac stimulant, and for most people the sensation is temporary. That said, not every palpitation is benign, and knowing the difference matters. These are prescription-only medicines assessed individually by a clinician; a prescriber reviews your cardiac history as part of any legitimate consultation before treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When patients notice a fluttering or racing sensation in their chest after starting Wegovy, the instinct is to blame the medicine acting directly on cardiac tissue. That's understandable (the feeling is alarming) but it usually isn't what's happening. Semaglutide is a GLP-1 receptor agonist; its primary targets are the gut, the pancreas, and appetite-regulating areas of the brain. It does not work like a stimulant drug that speeds the heart as a direct mechanism.
What does cause palpitations in this context is usually downstream. Nausea and reduced appetite (both common in the first few weeks) lead people to eat and drink less than usual. Dehydration reduces blood volume, which the heart compensates for by beating faster or more forcefully. You notice this as a thump or flutter, particularly when standing up quickly or after exertion. Low food intake can also lower blood potassium and magnesium, both of which influence heart rhythm. These are indirect, manageable causes, not a sign the medicine is damaging your heart.
There is also a reassuring counterpoint worth stating clearly. The SELECT cardiovascular outcomes trial enrolled over 17,000 adults with obesity and established cardiovascular disease and found that semaglutide 2.4mg reduced the risk of major cardiac events (heart attack, stroke, cardiovascular death) by around 20% over roughly three years. The NHS's patient information on semaglutide documents palpitations as an uncommon side effect, meaning they occur in fewer than one in ten but more than one in a hundred people using the medicine. NHS guidance on semaglutide lists the full side-effect profile and is worth reading alongside your Patient Information Leaflet.
Most semaglutide-related palpitations follow a predictable pattern: they appear in the first one to four weeks of a new dose, peak around the time nausea is at its worst, and then settle as the body adjusts. If you're experiencing them now, there's a reasonable chance you're in this window, and the practical response is focused on hydration and eating enough to maintain electrolyte balance, not stopping the medicine.
Sipping fluids steadily through the day, favouring foods with some sodium and potassium (soups, bananas, yoghurt), and avoiding sudden posture changes when the feeling is strong can all reduce the intensity. Your prescriber may also ask whether you're taking any other medicines that affect heart rate or rhythm, antihistamines, decongestants, and some blood pressure drugs interact in ways that make palpitations more likely. If you're considering the broader cardiac effects of the medicine, our page on Wegovy and heart health covers the evidence in more detail.
Palpitations that arrive weeks into treatment, long after the initial adjustment, are a different matter. So are episodes that come on suddenly at rest, last more than a few minutes, or happen repeatedly without an obvious trigger. These deserve a call to your GP or prescriber the same day rather than a watchful wait.
This is the most important section on this page. Seek urgent medical attention if palpitations are accompanied by any of the following: chest tightness or pain, breathlessness at rest, dizziness or fainting, a heart rate that feels very fast and won't slow down, or a sensation of the heart stopping and restarting. Call 999 if the symptoms are severe or sudden. These presentations go beyond what dehydration or a dose adjustment explains.
You should also be aware that the MHRA monitors all medicines through its Yellow Card scheme. If you experience a side effect you consider serious or unexpected (including cardiac symptoms) you can report it directly at yellowcard.mhra.gov.uk. These reports help regulators detect patterns that inform prescribing guidance.
When speaking to any clinician about palpitations on Wegovy, it helps to note the timing (after eating, at rest, on standing), the duration, how fast the heart felt, and whether anything triggered or relieved it. Mention your current dose and when you last increased it. If your resting heart rate has changed noticeably since starting treatment, that context matters too, and if you are pregnant or planning a pregnancy, our guidance on getting pregnant on Wegovy is also relevant to share with your clinician.
One reason palpitations catch people off guard is that some online prescribers do very little in the way of upfront assessment. A legitimate clinical review before starting Wegovy should include your cardiac history, current medicines, and blood pressure. At nume, a GPhC-registered Independent Prescriber reads your answers personally (a real clinician, not an automated form) and flags anything in your history that would affect how safely you can use semaglutide.
If cost is part of the picture for you, the Wegovy price comparison page covers what's typically included in a private prescription and what isn't. On the Wegovy overview, you'll find broader information about how the treatment works and who it's licensed for. The right starting point, if you haven't yet begun treatment or want a review of your current one, is a free consultation with our prescribers.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.